Key Insights
The global mastitis market is projected to reach $1.3 billion by 2025, driven by a robust compound annual growth rate (CAGR) of 7.2%. This expansion is attributed to increasing global dairy consumption, necessitating greater livestock production and consequently, a higher prevalence of mastitis. Advancements in diagnostic tools, including enhanced somatic cell count (SCC) testing and rapid detection kits, facilitate early identification and treatment, bolstering market growth. The widespread adoption of preventative strategies, such as improved milking parlor hygiene and vaccination programs, is also a significant contributing factor. Intra-mammary administration routes are favored for their targeted efficacy, while the lactating period segment dominates therapy-based segmentation due to the ongoing need for treatment during milk production. Antibiotics currently lead the product segment, though growing concerns about antibiotic resistance are spurring interest in alternative therapies like vaccines and enhanced hygiene protocols. North America and Europe presently hold substantial market shares, with the Asia-Pacific region anticipated to experience considerable growth driven by expanding dairy farming and increasing livestock populations.
Mastitis Market Market Size (In Billion)
Market restraints include the high cost of advanced diagnostic and treatment options, which can impede access, particularly in developing economies. Heightened regulatory scrutiny on antibiotic use in livestock is also encouraging the exploration of alternative therapeutic strategies, potentially influencing the market dynamics of antibiotic-based treatments. The emergence of antibiotic-resistant bacterial strains presents further treatment complexities, underscoring the need for continuous research and development of novel treatment modalities. Key market players such as Elanco, Boehringer Ingelheim, and Zoetis are actively contributing to market innovation through the introduction of new products and improved diagnostic tools. Future market growth will be contingent upon ongoing advancements in diagnostics, treatment options, and the evolving regulatory landscape surrounding antibiotic usage in dairy farming.
Mastitis Market Company Market Share
Mastitis Market Analysis: Forecast to 2033
This comprehensive report delivers actionable insights into the global Mastitis Market for stakeholders in veterinary pharmaceuticals and animal health. Spanning 2019-2033, with a specific focus on 2025, the report details market dynamics, leading players, emerging trends, and future growth prospects. Leveraging extensive primary and secondary research, the report provides accurate and reliable data for informed strategic decisions. Download this report to gain a competitive advantage in this dynamic market.
Mastitis Market Dynamics & Concentration
The global Mastitis Market exhibits a moderately concentrated landscape, with several key players holding significant market share. The market is characterized by intense competition, driven by continuous product innovation, evolving regulatory frameworks, and the emergence of substitute therapies. The increasing prevalence of mastitis in dairy cattle, coupled with rising awareness of animal welfare and the need for effective treatment, fuels market growth. Mergers and acquisitions (M&A) activity has been moderate, with a recorded xx M&A deals in the historical period (2019-2024), primarily focused on expanding product portfolios and geographical reach. Key market share holders include Elanco (Bayer AG), Boehringer Ingelheim International GmbH, and Zoetis Inc., collectively accounting for an estimated xx% of the market. Innovation is driven by the need for more effective, safer, and convenient treatment options, including the development of novel antibiotics, vaccines, and diagnostic tools. Stringent regulatory frameworks, particularly concerning antibiotic use, pose both challenges and opportunities, encouraging the development of antibiotic alternatives. The growing preference for preventive strategies and improved animal husbandry practices also shapes the market dynamics.
Mastitis Market Industry Trends & Analysis
The global Mastitis Market is projected to witness a CAGR of xx% during the forecast period (2025-2033), driven by several key factors. The increasing global dairy herd size and the rising prevalence of mastitis contribute significantly to market growth. Technological advancements in diagnostics, particularly point-of-care testing like the PortaReader launched in August 2022, are streamlining detection and treatment. Consumer preference for high-quality dairy products and concerns about antibiotic residues in milk are fueling the demand for effective mastitis control solutions. The competitive landscape is highly dynamic, with established players constantly innovating and smaller companies entering the market with niche products. Market penetration of advanced diagnostic tools remains relatively low, presenting significant growth opportunities. The growing focus on sustainable and environmentally friendly solutions is also influencing market trends, creating demand for antibiotic alternatives and eco-friendly treatment approaches. The shift towards preventive strategies, including improved hygiene protocols and vaccination programs, further contributes to market growth.
Leading Markets & Segments in Mastitis Market
The North American region currently dominates the Mastitis Market, followed by Europe. This dominance is attributed to factors such as a high density of dairy farms, advanced veterinary infrastructure, and robust regulatory frameworks.
Key Drivers by Segment:
- By Route of Administration: Intra-mammary administration holds the largest market share due to its targeted delivery and efficacy. Systemic administration is gaining traction due to its convenience in treating severe cases.
- By Therapy: Treatment during the lactating period is currently the dominant segment, due to the higher incidence of mastitis during this period. The dry-period treatment segment is experiencing moderate growth due to its role in preventing future infections.
- By End User: Hospitals and clinics, followed by veterinary centers, are the primary end-users. Other end-users (e.g., individual farmers) represent a significant, albeit fragmented, market segment.
- By Type: Clinical mastitis accounts for a larger share than subclinical mastitis due to its visible symptoms and the need for immediate treatment. Subclinical mastitis detection and prevention are gaining importance, fueled by the development of advanced diagnostic tools.
- By Product: Antibiotics currently dominate the market, followed by surgery and vaccines. Pain killers and other products are emerging as niche segments, driven by a need for alternative therapies and improved animal welfare.
Mastitis Market Product Developments
Recent product innovations focus on improving diagnostic accuracy, enhancing treatment efficacy, and reducing the reliance on antibiotics. The launch of the PortaReader, a handheld device for detecting subclinical mastitis, exemplifies this trend. The development of novel vaccines and alternative therapies, such as those being developed by Mileutis Ltd., are key drivers of innovation. These developments aim to address the challenges posed by antibiotic resistance and improve the overall management of mastitis in dairy herds. The focus on user-friendly, cost-effective, and accurate diagnostic tools is driving market evolution.
Key Drivers of Mastitis Market Growth
Technological advancements in diagnostics and therapeutics are key growth drivers. The development of rapid, point-of-care diagnostic tools improves early detection and timely treatment. Improved understanding of mastitis pathogenesis and the development of more effective vaccines are contributing to market expansion. Furthermore, the increasing awareness of animal welfare and the rising demand for safe and high-quality dairy products drive market growth. Government regulations and initiatives promoting sustainable animal farming practices also play a crucial role. For instance, the investment in Mileutis Ltd. highlights the industry shift towards antibiotic alternatives.
Challenges in the Mastitis Market
The high cost of treatment and diagnostic tools, particularly in developing countries, remains a significant barrier. The emergence of antibiotic resistance poses a substantial challenge, necessitating the development of alternative therapies. Regulatory hurdles concerning the approval and use of new therapies and diagnostic tools also slow market penetration. Supply chain disruptions and the availability of skilled personnel for diagnosis and treatment can hinder market expansion. These challenges contribute to variations in market growth across different regions and segments.
Emerging Opportunities in Mastitis Market
The development and adoption of novel antibiotics and alternative therapies, such as phage therapy and immunotherapies, represent key opportunities. Strategic partnerships between diagnostic companies, pharmaceutical firms, and dairy farmers can enhance the market. Expansion into emerging markets with a high prevalence of mastitis, coupled with improved veterinary infrastructure and awareness campaigns, provides substantial growth potential. The rising demand for personalized medicine approaches in veterinary care also presents a significant opportunity.
Leading Players in the Mastitis Market Sector
- Elanco (Bayer AG)
- Boehringer Ingelheim International GmbH
- Advanced Animal Diagnostics
- Merck & Co Inc
- Ceva
- Nimrod Veterinary Products Ltd
- ImmuCell Corporation
- West Way Health
- Norbrook
- DeLaval
- Zoetis Inc
Key Milestones in Mastitis Market Industry
- October 2022: NovaQuest Capital Management invested over USD 20 Million in Mileutis Ltd., accelerating the development of antibiotic-reducing mastitis treatments.
- August 2022: PortaCheck launched the PortaReader, a handheld device for on-farm subclinical mastitis detection, enhancing early intervention.
Strategic Outlook for Mastitis Market
The Mastitis Market is poised for significant growth, driven by technological advancements, increasing awareness, and the need for effective mastitis control. Strategic partnerships and investments in research and development will shape future market dynamics. The focus on preventive strategies and the development of alternative therapies will continue to drive innovation. Expansion into emerging markets and the adoption of sustainable practices will unlock further growth potential. The market's future hinges on addressing challenges related to antibiotic resistance and ensuring access to affordable and effective solutions globally.
Mastitis Market Segmentation
-
1. Type
- 1.1. Clinical Mastitis
- 1.2. Sub-clinical Mastitis
-
2. Product
- 2.1. Antibiotics
- 2.2. Surgery
- 2.3. Vaccines
- 2.4. Pain Killers
- 2.5. Other Products
-
3. Route of Administration
- 3.1. Intra-mammary
- 3.2. Systemic
-
4. Therapy
- 4.1. Lactating Period
- 4.2. Dry Period
-
5. End User
- 5.1. Hospitals and Clinics
- 5.2. Veterinary Centers
- 5.3. Other End Users
Mastitis Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Mastitis Market Regional Market Share
Geographic Coverage of Mastitis Market
Mastitis Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.2% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Incidence of the Disease; Increasing Product Launches for Animal Healthcare; Technological Advancements in the Field of Drug Discovery and Development
- 3.3. Market Restrains
- 3.3.1. Rising Threat of Antibiotic Resistance; Lack of Awareness About the Disease
- 3.4. Market Trends
- 3.4.1. Clinical Mastitis is Expected to Account for the Largest Market Share During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Clinical Mastitis
- 5.1.2. Sub-clinical Mastitis
- 5.2. Market Analysis, Insights and Forecast - by Product
- 5.2.1. Antibiotics
- 5.2.2. Surgery
- 5.2.3. Vaccines
- 5.2.4. Pain Killers
- 5.2.5. Other Products
- 5.3. Market Analysis, Insights and Forecast - by Route of Administration
- 5.3.1. Intra-mammary
- 5.3.2. Systemic
- 5.4. Market Analysis, Insights and Forecast - by Therapy
- 5.4.1. Lactating Period
- 5.4.2. Dry Period
- 5.5. Market Analysis, Insights and Forecast - by End User
- 5.5.1. Hospitals and Clinics
- 5.5.2. Veterinary Centers
- 5.5.3. Other End Users
- 5.6. Market Analysis, Insights and Forecast - by Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Middle East and Africa
- 5.6.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. Clinical Mastitis
- 6.1.2. Sub-clinical Mastitis
- 6.2. Market Analysis, Insights and Forecast - by Product
- 6.2.1. Antibiotics
- 6.2.2. Surgery
- 6.2.3. Vaccines
- 6.2.4. Pain Killers
- 6.2.5. Other Products
- 6.3. Market Analysis, Insights and Forecast - by Route of Administration
- 6.3.1. Intra-mammary
- 6.3.2. Systemic
- 6.4. Market Analysis, Insights and Forecast - by Therapy
- 6.4.1. Lactating Period
- 6.4.2. Dry Period
- 6.5. Market Analysis, Insights and Forecast - by End User
- 6.5.1. Hospitals and Clinics
- 6.5.2. Veterinary Centers
- 6.5.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. Europe Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. Clinical Mastitis
- 7.1.2. Sub-clinical Mastitis
- 7.2. Market Analysis, Insights and Forecast - by Product
- 7.2.1. Antibiotics
- 7.2.2. Surgery
- 7.2.3. Vaccines
- 7.2.4. Pain Killers
- 7.2.5. Other Products
- 7.3. Market Analysis, Insights and Forecast - by Route of Administration
- 7.3.1. Intra-mammary
- 7.3.2. Systemic
- 7.4. Market Analysis, Insights and Forecast - by Therapy
- 7.4.1. Lactating Period
- 7.4.2. Dry Period
- 7.5. Market Analysis, Insights and Forecast - by End User
- 7.5.1. Hospitals and Clinics
- 7.5.2. Veterinary Centers
- 7.5.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Asia Pacific Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. Clinical Mastitis
- 8.1.2. Sub-clinical Mastitis
- 8.2. Market Analysis, Insights and Forecast - by Product
- 8.2.1. Antibiotics
- 8.2.2. Surgery
- 8.2.3. Vaccines
- 8.2.4. Pain Killers
- 8.2.5. Other Products
- 8.3. Market Analysis, Insights and Forecast - by Route of Administration
- 8.3.1. Intra-mammary
- 8.3.2. Systemic
- 8.4. Market Analysis, Insights and Forecast - by Therapy
- 8.4.1. Lactating Period
- 8.4.2. Dry Period
- 8.5. Market Analysis, Insights and Forecast - by End User
- 8.5.1. Hospitals and Clinics
- 8.5.2. Veterinary Centers
- 8.5.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Middle East and Africa Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. Clinical Mastitis
- 9.1.2. Sub-clinical Mastitis
- 9.2. Market Analysis, Insights and Forecast - by Product
- 9.2.1. Antibiotics
- 9.2.2. Surgery
- 9.2.3. Vaccines
- 9.2.4. Pain Killers
- 9.2.5. Other Products
- 9.3. Market Analysis, Insights and Forecast - by Route of Administration
- 9.3.1. Intra-mammary
- 9.3.2. Systemic
- 9.4. Market Analysis, Insights and Forecast - by Therapy
- 9.4.1. Lactating Period
- 9.4.2. Dry Period
- 9.5. Market Analysis, Insights and Forecast - by End User
- 9.5.1. Hospitals and Clinics
- 9.5.2. Veterinary Centers
- 9.5.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. South America Mastitis Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Type
- 10.1.1. Clinical Mastitis
- 10.1.2. Sub-clinical Mastitis
- 10.2. Market Analysis, Insights and Forecast - by Product
- 10.2.1. Antibiotics
- 10.2.2. Surgery
- 10.2.3. Vaccines
- 10.2.4. Pain Killers
- 10.2.5. Other Products
- 10.3. Market Analysis, Insights and Forecast - by Route of Administration
- 10.3.1. Intra-mammary
- 10.3.2. Systemic
- 10.4. Market Analysis, Insights and Forecast - by Therapy
- 10.4.1. Lactating Period
- 10.4.2. Dry Period
- 10.5. Market Analysis, Insights and Forecast - by End User
- 10.5.1. Hospitals and Clinics
- 10.5.2. Veterinary Centers
- 10.5.3. Other End Users
- 10.1. Market Analysis, Insights and Forecast - by Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Elanco (Bayer AG)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Boehringer Ingelheim International GmbH
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Advanced Animal Diagnostics
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Merck & Co Inc
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Ceva
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Nimrod Veterinary Products Ltd
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 ImmuCell Corporation
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 West Way Health
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Norbrook
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 DeLaval
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Zoetis Inc
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.1 Elanco (Bayer AG)
List of Figures
- Figure 1: Global Mastitis Market Revenue Breakdown (billion, %) by Region 2025 & 2033
- Figure 2: North America Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 3: North America Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 4: North America Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 5: North America Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 6: North America Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 7: North America Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 8: North America Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 9: North America Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 10: North America Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 11: North America Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 12: North America Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 13: North America Mastitis Market Revenue Share (%), by Country 2025 & 2033
- Figure 14: Europe Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 15: Europe Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 16: Europe Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 17: Europe Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 18: Europe Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 19: Europe Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 20: Europe Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 21: Europe Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 22: Europe Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 23: Europe Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 24: Europe Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 25: Europe Mastitis Market Revenue Share (%), by Country 2025 & 2033
- Figure 26: Asia Pacific Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 27: Asia Pacific Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 28: Asia Pacific Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 29: Asia Pacific Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 30: Asia Pacific Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 31: Asia Pacific Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 32: Asia Pacific Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 33: Asia Pacific Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 34: Asia Pacific Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 35: Asia Pacific Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 36: Asia Pacific Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 37: Asia Pacific Mastitis Market Revenue Share (%), by Country 2025 & 2033
- Figure 38: Middle East and Africa Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 39: Middle East and Africa Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 40: Middle East and Africa Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 41: Middle East and Africa Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 42: Middle East and Africa Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 43: Middle East and Africa Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 44: Middle East and Africa Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 45: Middle East and Africa Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 46: Middle East and Africa Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 47: Middle East and Africa Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 48: Middle East and Africa Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 49: Middle East and Africa Mastitis Market Revenue Share (%), by Country 2025 & 2033
- Figure 50: South America Mastitis Market Revenue (billion), by Type 2025 & 2033
- Figure 51: South America Mastitis Market Revenue Share (%), by Type 2025 & 2033
- Figure 52: South America Mastitis Market Revenue (billion), by Product 2025 & 2033
- Figure 53: South America Mastitis Market Revenue Share (%), by Product 2025 & 2033
- Figure 54: South America Mastitis Market Revenue (billion), by Route of Administration 2025 & 2033
- Figure 55: South America Mastitis Market Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 56: South America Mastitis Market Revenue (billion), by Therapy 2025 & 2033
- Figure 57: South America Mastitis Market Revenue Share (%), by Therapy 2025 & 2033
- Figure 58: South America Mastitis Market Revenue (billion), by End User 2025 & 2033
- Figure 59: South America Mastitis Market Revenue Share (%), by End User 2025 & 2033
- Figure 60: South America Mastitis Market Revenue (billion), by Country 2025 & 2033
- Figure 61: South America Mastitis Market Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 2: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 3: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 4: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 5: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 6: Global Mastitis Market Revenue billion Forecast, by Region 2020 & 2033
- Table 7: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 8: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 9: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 10: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 11: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 12: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 13: United States Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 14: Canada Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 15: Mexico Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 16: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 17: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 18: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 19: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 20: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 21: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 22: Germany Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 23: United Kingdom Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 24: France Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 25: Italy Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 26: Spain Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 27: Rest of Europe Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 28: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 29: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 30: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 31: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 32: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 33: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 34: China Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 35: Japan Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 36: India Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 37: Australia Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 38: South Korea Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 39: Rest of Asia Pacific Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 40: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 41: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 42: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 43: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 44: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 45: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 46: GCC Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 47: South Africa Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 48: Rest of Middle East and Africa Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 49: Global Mastitis Market Revenue billion Forecast, by Type 2020 & 2033
- Table 50: Global Mastitis Market Revenue billion Forecast, by Product 2020 & 2033
- Table 51: Global Mastitis Market Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 52: Global Mastitis Market Revenue billion Forecast, by Therapy 2020 & 2033
- Table 53: Global Mastitis Market Revenue billion Forecast, by End User 2020 & 2033
- Table 54: Global Mastitis Market Revenue billion Forecast, by Country 2020 & 2033
- Table 55: Brazil Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 56: Argentina Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
- Table 57: Rest of South America Mastitis Market Revenue (billion) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Mastitis Market?
The projected CAGR is approximately 7.2%.
2. Which companies are prominent players in the Mastitis Market?
Key companies in the market include Elanco (Bayer AG), Boehringer Ingelheim International GmbH, Advanced Animal Diagnostics, Merck & Co Inc, Ceva, Nimrod Veterinary Products Ltd, ImmuCell Corporation, West Way Health, Norbrook, DeLaval, Zoetis Inc.
3. What are the main segments of the Mastitis Market?
The market segments include Type, Product, Route of Administration, Therapy, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 1.3 billion as of 2022.
5. What are some drivers contributing to market growth?
Rising Incidence of the Disease; Increasing Product Launches for Animal Healthcare; Technological Advancements in the Field of Drug Discovery and Development.
6. What are the notable trends driving market growth?
Clinical Mastitis is Expected to Account for the Largest Market Share During the Forecast Period.
7. Are there any restraints impacting market growth?
Rising Threat of Antibiotic Resistance; Lack of Awareness About the Disease.
8. Can you provide examples of recent developments in the market?
In October 2022, NovaQuest Capital Management invested over USD 20 million in Mileutis Ltd, an Israeli biopharmaceuticals company, to help mitigate the use of antibiotics in animals. Mileutics is in the advanced stages of developing a product that treats and prevents bovine mastitis.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Mastitis Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Mastitis Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Mastitis Market?
To stay informed about further developments, trends, and reports in the Mastitis Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence